In bladder cancer cells, exposure to CDDP induces the expression of the tumor suppressor protein p53, which subsequently upregulates galectin-7 expression, thereby increasing chemosensitivity to CDDP. This evidence concerns the gene LGALS7 and urinary bladder cancer.